Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Rigshospitalet, Denmark
Duke University
RenJi Hospital
Cambridge University Hospitals NHS Foundation Trust
Changzhou No.2 People's Hospital
Atara Biotherapeutics